Bio-TT

Bio-TT

Manufacturer:

Bio Farma

Distributor:

BioNet-Asia

Marketer:

BioNet-Asia
Concise Prescribing Info
Contents
Purified tetanus toxoid
Indications/Uses
Active immunization & prevention of neonatal tetanus by immunizing women of childbearing age.
Dosage/Direction for Use
Primary immunization 2 doses of 0.5 mL IM/SC at least 4 wk apart followed by 3rd dose 6 mth after 2nd dose. Maintenance immunization of childbearing women Recommended dose: 5 doses. 4th dose should be given at least 1 yr after 3rd dose, & 5th dose at least 1 yr after 4th dose.
Contraindications
Hypersensitivity. Severe reactions to a previous dose of tetanus toxoid. Defer immunization in cases of febrile illness or acute infection.
Adverse Reactions
Acute allergic reactions, dyspnea, urticaria, angioneurotic oedema, anaphylaxis.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07AM01 - tetanus toxoid ; Belongs to the class of tetanus bacterial vaccines.
Presentation/Packing
Form
Bio-TT inj 10 Lf/0.5 mL
Packing/Price
10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in